0001209191-22-015590.txt : 20220303 0001209191-22-015590.hdr.sgml : 20220303 20220303170108 ACCESSION NUMBER: 0001209191-22-015590 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOLGER JOHN C CENTRAL INDEX KEY: 0001183863 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37894 FILM NUMBER: 22710019 MAIL ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE STREET 2: SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulgent Genetics, Inc. CENTRAL INDEX KEY: 0001674930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 812621304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 BUSINESS PHONE: 626-350-0537 MAIL ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 FORMER COMPANY: FORMER CONFORMED NAME: Fulgent Diagnostics, Inc. DATE OF NAME CHANGE: 20160517 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-01 0 0001674930 Fulgent Genetics, Inc. FLGT 0001183863 BOLGER JOHN C C/O FULGENT GENETICS, INC. 4978 SANTA ANITA AVE. TEMPLE CITY CA 91780 1 0 0 0 Common Stock 2022-03-01 4 M 0 625 3.925 A 2625 D Common Stock 2022-03-01 4 S 0 625 61.4202 D 2000 D Common Stock 2022-03-01 4 M 0 625 5.8098 A 2625 D Common Stock 2022-03-01 4 S 0 625 61.402 D 2000 D Common Stock 2022-03-01 4 M 0 625 15.82 A 2625 D Common Stock 2022-03-01 4 S 0 625 61.2681 D 2000 D Stock Option (Right to Buy) 3.925 2022-03-01 4 M 0 625 0.00 D 2028-05-18 Common Stock 625 313 D Stock Option (Right to Buy) 5.8098 2022-03-01 4 M 0 625 0.00 D 2029-05-30 Common Stock 625 1563 D Stock Option (Right to Buy) 15.82 2022-03-01 4 M 0 625 0.00 D 2030-05-26 Common Stock 625 2813 D The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. /s/ Paul Kim, as Attorney-in-fact 2022-03-03